ceftazidime mip 2g süste-/infusioonilahuse pulber
mip pharma gmbh - tseftasidiim - süste-/infusioonilahuse pulber - 2g 50ml 1tk; 2g 50ml 10tk; 2g 50ml 5tk
xorimax kaetud tablett
sandoz gmbh - tsefuroksiim - kaetud tablett - 500mg 10tk; 500mg 24tk; 500mg 8tk; 500mg 12tk
ceftazidime fresenius kabi 2000mg süste-/infusioonilahuse pulber
fresenius kabi polska sp. z o.o. - tseftasidiim - süste-/infusioonilahuse pulber - 2000mg 10tk; 2000mg 1tk
ceftazidime fresenius kabi 1000mg süstelahuse pulber
fresenius kabi polska sp. z o.o. - tseftasidiim - süstelahuse pulber - 1000mg 10tk; 1000mg 1tk
tercef süste-/infusioonilahuse pulber
teva b.v. - tseftriaksoon - süste-/infusioonilahuse pulber - 1g 1tk; 1g 5tk
sunitinib accord
accord healthcare s.l.u. - sunitiniib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastilised ained - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
sunitinib norameda kõvakapsel
norameda uab - sunitiniib - kõvakapsel - 12,5mg 30tk; 12,5mg 28tk
sunitinib krka kõvakapsel
krka, d.d., novo mesto - sunitiniib - kõvakapsel - 25mg 14tk; 25mg 10tk; 25mg 7tk; 25mg 20tk; 25mg 21tk; 25mg 28tk
sunitinib krka kõvakapsel
krka, d.d., novo mesto - sunitiniib - kõvakapsel - 12,5mg 14tk; 12,5mg 30tk; 12,5mg 21tk; 12,5mg 7tk; 12,5mg 28tk; 12,5mg 10tk; 12,5mg 20tk
sunitinib krka kõvakapsel
krka, d.d., novo mesto - sunitiniib - kõvakapsel - 50mg 21tk; 50mg 10tk; 50mg 14tk; 50mg 20tk; 50mg 7tk; 50mg 28tk